Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate an improvement in progression-free survival (PFS) in patients with mCRC treated with sunitinib plus FOLFOX compared with bevacizumab plus FOLFOX in the first-line treatment setting.
Inclusion criteria
- Metastatic colorectal cancer